Key points are not available for this paper at this time.
Inhibition of ITGB1 might be a new therapeutic method in colorectal cancer.
Yang et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: